In vitro modulation of cisplatin accumulation in human ovarian carcinoma cells by pharmacologic alteration of microtubules
about
Dihydrodiol dehydrogenases regulate the generation of reactive oxygen species and the development of cisplatin resistance in human ovarian carcinoma cells.Resistance to platinum-based chemotherapy in lung cancer cell lines.Cross-resistance between cisplatin, antimony potassium tartrate, and arsenite in human tumor cells.Synergistic interaction between cisplatin and taxol in human ovarian carcinoma cells in vitroTumour cells surviving in vivo cisplatin chemotherapy display elevated c-myc expression.Cisplatin resistance in human cervical, ovarian and lung cancer cells.Increased expression of dihydrodiol dehydrogenase induces resistance to cisplatin in human ovarian carcinoma cells.Paclitaxel and SN-38 overcome cisplatin resistance of ovarian cancer cell lines by down-regulating the influx and efflux system of cisplatin.Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin.Cross-resistance and collateral sensitivity to natural product drugs in cisplatin-sensitive and -resistant rat lymphoma and human ovarian carcinoma cells.Inauhzin(c) inactivates c-Myc independently of p53.Reversal of radiation-induced cisplatin resistance in murine fibrosarcoma cells by selective modulation of the cyclic GMP-dependent transduction pathway.Cisplatin resistance in mouse fibrosarcoma cells after low-dose irradiation in vitro and in vivo.Increased expression of T-plastin gene in cisplatin-resistant human cancer cells: identification by mRNA differential display.Schedule-dependent and -independent antitumor activity of paclitaxel-based combination chemotherapy against M-109 murine lung carcinoma in vivo.
P2860
Q33755882-127DB36A-BA4E-4F9F-99B2-12BE413FF159Q34214006-1EA8174B-D9CE-4AF3-8F96-F80DC710F0BBQ35553372-747236AB-E8CA-46B1-B402-A85BB6B7DD63Q35977724-9DADF336-E517-498D-801D-D0E4983E8D54Q36134626-D90FD2C6-ABC4-47A5-BA31-492CD03C3B13Q38884442-2FEFFBAE-C06D-4012-AE6B-D011D7510192Q40751233-A0040E24-0928-4E28-97D9-AA79E94CCFB3Q40767821-AD805207-2792-4DFB-AE9A-F262C15C128CQ41202524-7CA7CFB0-93F6-47C1-91C5-351235BD0EC2Q41254059-206FEBA5-54D9-4CA5-B1FC-0AE61DD0D421Q42139293-0D49CD79-198B-47EF-BC3B-3E4C7C10FF22Q42146868-3A1E534D-E4C8-49C2-87B3-8D80F622A5A4Q42590267-2BC60AD8-D994-4AF9-A9AE-99231FA025DDQ48057968-CA8AC11C-2429-4DDA-89A1-ACD3A26DFE4FQ55024941-9254A4A1-4654-4A02-8344-DA568E52D6B2
P2860
In vitro modulation of cisplatin accumulation in human ovarian carcinoma cells by pharmacologic alteration of microtubules
description
1993 nî lūn-bûn
@nan
1993 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
In vitro modulation of cisplat ...... gic alteration of microtubules
@ast
In vitro modulation of cisplat ...... gic alteration of microtubules
@en
In vitro modulation of cisplat ...... gic alteration of microtubules
@nl
type
label
In vitro modulation of cisplat ...... gic alteration of microtubules
@ast
In vitro modulation of cisplat ...... gic alteration of microtubules
@en
In vitro modulation of cisplat ...... gic alteration of microtubules
@nl
prefLabel
In vitro modulation of cisplat ...... gic alteration of microtubules
@ast
In vitro modulation of cisplat ...... gic alteration of microtubules
@en
In vitro modulation of cisplat ...... gic alteration of microtubules
@nl
P2093
P2860
P356
P1476
In vitro modulation of cisplat ...... gic alteration of microtubules
@en
P2093
A P Jekunen
D R Shalinsky
F Thiebaut
R D Christen
S B Howell
P2860
P304
P356
10.1172/JCI116585
P407
P577
1993-07-01T00:00:00Z